Company Filing History:
Years Active: 2005
Title: Changyou Chen: Innovator in RRP Protein Research
Introduction
Changyou Chen is a notable inventor based in Castro Valley, California. He has made significant contributions to the field of biotechnology, particularly in the study of rhomboid-related proteins (RRPs) and their implications in cancer research.
Latest Patents
Changyou Chen holds a patent titled "Human RRP sequences and methods of use." This patent focuses on the role of RRPs in the EGFR signaling pathway. It includes transgenic, nonhuman mammals that contain a transgene encoding an RRP polypeptide. The patent also outlines methods for modulating the interaction of RRP proteins with their pathway members. Additionally, it provides techniques for screening agents that can modulate the interaction of RRP polypeptides with RRP binding targets, such as RRP-specific antibodies and small molecules identified through high throughput screens. The modulating agents identified can be utilized to specifically inhibit the growth of tumor cells that overexpress RRP proteins.
Career Highlights
Changyou Chen is currently associated with Exelixis, Inc., a company known for its focus on developing innovative cancer therapies. His work has been instrumental in advancing the understanding of RRPs and their potential therapeutic applications.
Collaborations
Some of his notable coworkers include Mario N Lioubin and Lori Friedman, who have collaborated with him on various projects related to RRP research.
Conclusion
Changyou Chen's contributions to the field of biotechnology, particularly through his patent on RRP proteins, highlight his role as an innovator in cancer research. His work continues to pave the way for new therapeutic strategies in the fight against cancer.